Back to Stocks

Aurobindo Pharma Limited

AUROPHARMANSEHealthcare

Aurobindo Pharma Limited
1,288.90 3.32%(+41.40)

Previous Close

1,247.50

Last Updated

20 Mar, 07:18 am

Market Cap

N/A

P/E Ratio

21.481667

52W High

1,319.80

52W Low

1,010.00

Open

₹1,255.00

High

₹1,269.00

Low

₹1,240.00

Volume

5,93,069

Price Chart with Technical Indicators

• Blue line: Stock price

• Yellow dashed line: 20-day moving average

• Red dashed line: 50-day moving average

• Gray line: Trading volume (scaled for visualization)

Performance Analysis

52W Range Position

90.0%

Above midpoint

From 52W High

2.3%

From 52W Low

+27.6%

Average Price

₹1247.50

Trading Metrics

Volume

5,93,069

Avg Volume

8,16,613

Volume Ratio

0.73x

Normal

Volatility

N/A

Moderate

Financial Fundamentals

Profit

0.00 Cr

Debt

0.00 Cr

Risk Assessment

Overall Risk LevelLow

Price Stability

Volatile

Market Position

Strong

Liquidity

Moderate

Valuation Metrics

P/E Ratio

21.481667

Fair value

About Aurobindo Pharma Limited

Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Latest News

No news available for this stock.